Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 76 peer-reviewed journal articles Updated
Endocrinology

Autoimmune polyendocrinopathy type 1 (APS-1 / APECED): A Patient Guide

At a Glance

APS-1 (APECED) is a rare immune disorder caused by changes in the AIRE gene that can affect hormone glands and other organs. Symptoms vary and may appear years apart, so treatment and monitoring must be tailored to each person’s complications.

Important: APS-1 is a highly variable condition. You may not develop every complication listed in this guide. This resource is not a universal testing checklist, and you should never start, stop, or change hormone, calcium, antifungal, or immunosuppressive treatments without direct guidance from your clinician.

Autoimmune polyendocrinopathy type 1 (APS-1), also known as APECED, is an ultra-rare genetic disorder that fundamentally changes how the immune system views the body. In a healthy immune system, a specialized training process in the thymus ensures that immune cells can distinguish between foreign invaders and the body’s own healthy tissues. In APS-1, a mutation in the AIRE gene disrupts this training, allowing some immune cells to escape into the bloodstream and mistakenly target various organs and glands [1][2].

This condition is most famous for a “classic triad” of symptoms: chronic mucocutaneous candidiasis (persistent yeast infections), hypoparathyroidism (low blood calcium), and Addison’s disease (adrenal insufficiency). However, these three signs rarely appear all at once; they often emerge years apart, and many patients experience other “non-triad” symptoms first, such as unique skin rashes, defects in tooth enamel, or chronic digestive issues [3][4]. Because these early clues are so varied, the journey to a definitive diagnosis can be long and complex, but identifying the condition early is the key to managing complications [5].

Living with APS-1 requires a proactive and organized approach to health, tailored entirely to the specific manifestations you actually have. The most critical pillar of daily management is replacing the hormones that the body can no longer produce, such as cortisol for energy and stress response, or parathyroid hormone for calcium balance [6][7]. Alongside these daily treatments, patients with confirmed organ involvement must be expertly prepared for medical emergencies. If prescribed by your doctor, this includes having a clear “sick-day” plan for adrenal crisis—complete with an emergency injection kit—and knowing how to recognize the warning signs of dangerously low calcium, such as muscle spasms or tingling [8][9][10].

Because APS-1 can affect the lungs, liver, kidneys, and the health of the mouth and teeth, care is never a “one-specialist” job. Successful long-term management relies on a dedicated multidisciplinary team that monitors the body through targeted lab work and clinical exams [11][12]. This team provides the specific surveillance needed to catch early issues like lung inflammation or liver changes before they become severe. While the diagnosis is a life-changing event, a coordinated care team and a well-prepared family can manage the challenges of APS-1, focusing on safety and maintaining a high quality of life [13][14].

In this guide

6 chapters

01

Understanding Your APS-1 Diagnosis

Learn what an APS-1 diagnosis means, including AIRE gene inheritance, early signs, genetic testing, and why symptoms may develop gradually over many years.

02

Symptoms and Diagnostic Criteria

Learn how APS-1 (APECED) diagnostic criteria use the classic triad, early warning signs, anti-interferon antibodies, and AIRE gene testing to support diagnosis.

03

Managing Endocrine Complications

Learn how APS-1 endocrine complications are treated, including calcium, adrenal, thyroid, and sex hormone replacement, kidney monitoring, and crisis prevention.

04

Managing Non-Endocrine Complications

Learn how APS-1 (APECED) can affect the mouth, skin, lungs, liver, bowel, and kidneys, including warning signs, monitoring, and treatment risks to guide care.

05

Emergencies and Urgent Care

Learn about APS-1 emergency warning signs, including adrenal crisis and severe low calcium, plus prescribed sick-day plans, injections, and when to seek care.

06

Building Your Care Team and Monitoring

Learn how APS-1 (APECED) care teams coordinate specialists, lab tests, organ checks, and oral surveillance to monitor complications and guide follow-up.

Common questions in this guide

What is APS-1 (APECED)?
APS-1, also called APECED, is a rare inherited condition caused by a change in the AIRE gene. The immune system can mistakenly attack hormone-producing glands and other organs, and the pattern of health problems differs from person to person.
What are the main signs of APS-1?
The classic pattern includes long-lasting yeast infections, low blood calcium from parathyroid problems, and adrenal insufficiency, also called Addison’s disease. These problems may develop years apart, and early clues can instead include skin changes, weak tooth enamel, or ongoing digestive symptoms.
How is APS-1 diagnosed?
Diagnosis can take time because APS-1 symptoms vary and may appear years apart. Clinicians may use the pattern of affected organs and glands, genetic testing for the AIRE gene, clinical findings, and targeted laboratory tests to confirm the condition.
What treatments are used for APS-1?
Treatment depends on which organs are affected. It may include replacing hormones such as cortisol or parathyroid hormone, treating yeast infections or low calcium, and using immune-directed treatment when prescribed; never start, stop, or change these treatments without clinician guidance.
What emergencies should someone with APS-1 prepare for?
People with adrenal involvement need a clinician-directed sick-day plan and may need an emergency hydrocortisone injection kit for adrenal crisis. Very low calcium can cause tingling or muscle spasms, so ask your care team which symptoms require immediate emergency care.
What monitoring and specialists are needed for APS-1?
Care is usually shared among specialists because APS-1 can affect hormone glands, lungs, liver, kidneys, mouth, and teeth. A personalized schedule of examinations and laboratory tests helps the team look for new problems early.
Will everyone with APS-1 develop the same complications?
No. APS-1 is highly variable, and many people do not develop every complication listed in a general resource. Monitoring should be based on your own symptoms, test results, and confirmed organ involvement.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific AIRE gene mutations were found, and what do they tell us about the likely course of this condition?
  2. 2.Which specialists should we prioritize adding to our care team right now, based on my specific symptoms?
  3. 3.Can we establish a baseline 'surveillance schedule' for the endocrine, lung, and liver monitoring we need over the next year?
  4. 4.What are the specific warning signs for an adrenal or calcium emergency that should trigger an immediate ER visit for me?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    [Induction of central tolerance by the factor Aire: molecular and epigenetic regulation].

    Lopes N, Ferrier P, Irla M

    Medecine sciences : M/S 2015; (31(8-9)):742-7 doi:10.1051/medsci/20153108012.

    PMID: 26340833
  2. 2

    AAV9-mediated AIRE gene delivery clears circulating antibodies and tissue T-cell infiltration in a mouse model of autoimmune polyglandular syndrome type-1.

    Almaghrabi S, Azzouz M, Tazi Ahnini R

    Clinical & translational immunology 2020; (9(9)):e1166 doi:10.1002/cti2.1166.

    PMID: 32994995
  3. 3

    Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review.

    Sharifinejad N, Zaki-Dizaji M, Tebyanian S, et al.

    Expert review of clinical immunology 2021; (17(8)):807-817 doi:10.1080/1744666X.2021.1925543.

    PMID: 33957837
  4. 4

    Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

    Ferre EM, Rose SR, Rosenzweig SD, et al.

    JCI insight 2016; (1(13)).

    PMID: 27588307
  5. 5

    Performance of expanded diagnostic criteria for APECED in independent cohorts and implications for earlier diagnosis.

    Ferré EM, Pechacek J, Schmitt MM, et al.

    JCI insight 2026; (11(14)).

    PMID: 42484378
  6. 6

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647
  7. 7

    Impact of periprocedural subcutaneous parathyroid hormone on control of hypocalcaemia in APS-1/APECED patients undergoing invasive procedures.

    Winer KK, Schmitt MM, Ferre EMN, et al.

    Clinical endocrinology 2021; (94(3)):377-383 doi:10.1111/cen.14335.

    PMID: 32955743
  8. 8

    [Emergency card, emergency medication, and information leaflet for the prevention and treatment of adrenal crisis (Addison crisis): an Austrian consensus document].

    Pilz S, Krebs M, Bonfig W, et al.

    Journal fur klinische Endokrinologie und Stoffwechsel 2022; (15(1)):5-27 doi:10.1007/s41969-022-00155-2.

    PMID: 35251520
  9. 9

    Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.

    Miller BS, Spencer SP, Geffner ME, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2020; (68(1)):16-25 doi:10.1136/jim-2019-000999.

    PMID: 30819831
  10. 10

    Proton pump inhibitor induced hypocalcemia presenting with carpopedal spasm- a rare case report from Nepal.

    Pahari N, Pahari M, Ghimire S, et al.

    International journal of emergency medicine 2026; (19(1)).

    PMID: 42056855
  11. 11

    Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED): Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, and Management.

    Hamidi M, Kamrani M, Karami S, et al.

    Endocrine, metabolic & immune disorders drug targets 2026; doi:10.2174/0118715303511788260918112249.

    PMID: 42786839
  12. 12

    Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

    Ferré EMN, Schmitt MM, Lionakis MS

    Frontiers in pediatrics 2021; (9()):723532 doi:10.3389/fped.2021.723532.

    PMID: 34790633
  13. 13

    Approach to the patient with APS-1/APECED.

    Webb T, Pechacek J, Lionakis MS

    The Journal of clinical endocrinology and metabolism 2026; doi:10.1210/clinem/dgag282.

    PMID: 42460781
  14. 14

    Infections and demanding endocrine care contribute to increased mortality in patients with APECED.

    Borchers J, Mäkitie O, Laakso S

    European journal of endocrinology 2021; (185(5)):K13-K17.

    PMID: 34403360

This APS-1 information is for educational purposes only and does not constitute medical advice. Your care team should guide hormone, calcium, antifungal, immunosuppressive, and emergency treatments for your specific complications.

Get notified when new evidence is published on Autoimmune polyendocrinopathy type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.